5 completed, 2 active not recruiting, 2 recruiting, 1 available. 4 Not applicable, 3 Phase 2, 2 Phase 1, 2 Phase 4.
Follow Breast Neoplasm Malignant Female: new trials by email Literature Review of Breast Neoplasm Malignant Female trials Research Report on Breast Neoplasm Malignant Female
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer Supervised exercise - Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Neoplasm Malignant Female | Not applicable | Not yet recruiting | King Hamad University Hospital, Bahrain | 80 | 2026-09-01 | 2026-08-13 |
| Step Count and Treatment Response in Neoadjuvant Breast Cancer Huawei Fit 2 Smartwatch - Breast Neoplasm Malignant Female, Exercise | Recruiting | Ankara Etlik City Hospital | 82 | 2025-09-08 | 2026-10-08 | |
| Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer Omission of local therapies - Breast Neoplasm Malignant Female | Phase 2 | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 152 | 2025-07-25 | 2025-09-15 |
| Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy REGENERA breast implant implantation - Mastectomy, Segmental, Breast Neoplasm Malignant Female | Not applicable | Active not recruiting | Tensive SRL | 92 | 2023-09-29 | 2026-07-22 |
| Study of the Impact of DPD Activity on the Efficacy of Capecitabine DPD activity assessment, Capecitabine - Breast Neoplasm Malignant Female | Phase 2 | Active not recruiting | Centre Antoine Lacassagne | 155 | 2020-07-20 | 2026-06-02 |
| Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy Patients receive microporous polysaccharide hemospheres., Patients DO NOT receive microporous polysaccharide hemospheres. - Mastectomy, Lymphadenectomy | Phase 4 | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 120 | 2020-06-01 | 2025-02-13 |
| SBRT for Breast Cancer Oligometastases Stereotactic Body Radiotherapy - Breast Neoplasm Malignant Female | Not applicable | Unknown | King Hussein Cancer Center | 50 | 2020-06-01 | 2020-06-11 |
| Interest of Touch-massage in Hospital Day Care Women between 18 and 70 years old with an adjuvant breast cancer histologically characterized - Breast Neoplasm Malignant Female | Completed | Institut Cancerologie de l'Ouest | 36 | 2019-10-07 | 2022-04-22 | |
| PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells - Advanced Breast Cancer, Breast Neoplasm Malignant Female | Phase 1 / Phase 2 | Completed | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 15 | 2019-05-17 | 2023-04-13 |
| Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE) Letrozole, standard-stimulated cohort - Breast Neoplasm Malignant Female | Phase 4 | Terminated | Erasme University Hospital | 96 | 2019-02-25 | 2025-01-31 |
| Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients Questionnaires - Breast Neoplasm Malignant Female | Not applicable | Completed | Dr. Vera Trommet | 62 | 2018-01-10 | 2023-04-21 |
| Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) Olaparib, Radiation therapy - Breast Neoplasms, Triple-Negative, Breast Neoplasm Malignant Female | Phase 1 | Completed | Institut Curie | 24 | 2017-07-24 | 2025-11-24 |
| Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009 Gedatolisib - Breast Neoplasm Malignant Female | Available | Celcuity Inc | 2025-03-21 |
Breast Neoplasms (4) · Motor Activity (2) · Anxiety Disorders (1) · Pathologic Complete Response (1) · Radiation Injuries (1) · Sarcopenia (1) · Seroma (1) · Sleep Initiation and Maintenance Disorders (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Behavior (2) · Mental Disorders (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Atrophy (1) · Breast Neoplasms (1) · Disease Attributes (1) · Disease Progression (1) · Dyssomnias (1)
Adenosine Diphosphate (1) · Adenosine Diphosphate Ribose (1) · Capecitabine (1) · Immunophenotyping (1) · Letrozole (1) · Poly A (1) · Radiosurgery (1) · Radiotherapy (1) · Surveys and Questionnaires (1) · gedatolisib (1) · olaparib (1)
Ankara Etlik City Hospital (1) · Celcuity Inc (1) · Centre Antoine Lacassagne (1) · Dr. Vera Trommet (1) · Erasme University Hospital (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Institut Cancerologie de l'Ouest (1) · Institut Curie (1) · King Hamad University Hospital, Bahrain (1) · King Hussein Cancer Center (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Tensive SRL (1)
France (4) · Italy (3) · Spain (2) · Austria (1) · Bahrain (1) · Belgium (1) · China (1) · Jordan (1) · Monaco (1) · Turkey (Türkiye) (1) · United States (1)
Abdulmajeed Dayyat, MD (1) · Christine Decanter, MD (1) · Erwei Song, MD, PhD (1) · Galip Can Uyar, MD (1) · Isabelle Demeestere, MD, PhD (1) · Massimiliano Gennaro, MD (1) · Matteo Lambertini, MD, PhD (1) · Vera Trommet, Dr. (1)
PMID 32971187, PMID 36301572, PMID 40295450
2016 (1)